期刊文献+

吸入胰岛素研究新进展 被引量:2

下载PDF
导出
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2006年第4期313-314,共2页 Chinese Journal of Diabetes
  • 相关文献

参考文献12

  • 1Rave KM, Nosek L, Pena A, et al. Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro. Diabetes Care, 2005, 28:2400-2405.
  • 2Plank J, Balent B, Bock G, et al. Linear dose-response relationship of inhaled human insulin using AERx insulin diabetes management system (AERx@ iDMS) and subcutaneous human insulin in subjects with type I diabetes. Diabetes, 2004, 53(suppl 2) : A113.
  • 3Becker RH, Sha S, Frick AD, et al. The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin. Diabetes Care, 2006, 29:277 282.
  • 4Henry RR, Mudaliar SR, Howland WC,et al. Inhaled insulin using the AERx insulin diabetes management system in healthy and asthmatic subjects. Diabetes Care, 2003,26:764 769.
  • 5McElduff A, Mather LE, Kam PC, et al. Influence of acute upper respiratory tract infection on the absorption of inhaled insulin using the AERx insulin Diabetes Management System. Br J Clin Pharmacol, 2005, 59:546-551.
  • 6Edgerton DS, Neal DW, Scott M, et al. Inhalation of insulin (Exubera) is associated with augmented disposal of portally infused glucose in dogs. Diabetes, 2005, 54:1164-1170.
  • 7Barnett AH, for the Exubera Phase Ⅲ Study Group. Efficacy and one-year pulmonary of inhaled insulin (Exubera) as adjunctive therapy with metformin or glibenclamide in type 2 diabetes patients poorly controlled on oral agent monotherapy. Diabetes, 2004, 53(suppl 2) :A107.
  • 8Hermansen K, Ronnemaa T, Petersen AH, et al. Intensive therapy with inhaled insulin via the AERx insulin diabetes management system: a 12-week proof-of concept trial in patientswith type 2 diabetes. Diabetes Care, 2004, 27;162-167.
  • 9Heise T, Bott S, Tusek C, et al. The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin:a prospective randomized pharmacodynamic study. Diabetes Care,2005, 28:2161-2169.
  • 10Skyler J, for the Exubera Phase 2 Study Group. Sustained long-term efficacy and safety of inhaled insulin during 4 years of continuous therapy. Diabetes, 2004, 53(supp12):A115.

同被引文献15

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部